C07F9/40 - CPC Classification Index

ClassID:

95969 ⎘

C07F9/40 - CPC Classification

Classification description:

Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds with one or more P—C bonds; Phosphonic acids RP(=O)(OH); Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) Esters thereof

Sub-classes:

C07F9/4003 » {the acid moiety containing a substituent or a structure which is considered as characteristic} 4
C07F9/4068 » {Esters of pyrophosphonic acids; Esters of phosphonic acid anhydrides} 4
C07F9/4071 » {the ester moiety containing a substituent or a structure which is considered as characteristic} 18

Recent Application in this class:

20230147502

2023-05-11

Phosphonate linkers and their use to facilitate cellular retention of compounds

20210221831

2021-07-22

Trifluoromethyl alkenylphosphonate and preparation method therefor

20210179938

2021-06-17

Anti-oxidant compounds and compositions

20210026053

2021-01-28

Near-infrared absorbing composition, near-infrared absorbing film, and image sensor for solid-state imaging element

20210015930

2021-01-21

Phosphonate linkers and their use to facilitate cellular retention of compounds

20210008085

2021-01-14

USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLOGICAL DISEASES

20210000846

2021-01-07

USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLOGICAL DISEASES

20200246360

2020-08-06

Use of agonists of formyl peptide receptor 2 for treating dermatological diseases

20200148652

2020-05-14

Aminothiazole Derivatives Useful As Antiviral Agents

#10

20190382422

2019-12-19

SALICYLIC ACID DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, COMPOSITION THEREOF AND METHOD OF USE THEREOF

#11

20190263847

2019-08-29

Method for producing alkenyl phosphorus compound

#12

20190233449

2019-08-01

Glucokinase activators and methods of using same

#13

20190225634

2019-07-25

Nahlsgen optical resolution method

#14

20190169124

2019-06-06

Derivatives of indole for the treatment of cancer, viral infections and lung diseases

#15

20190153004

2019-05-23

Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases

#16

20190151339

2019-05-23

OLIGOMER-FOSCARNET CONJUGATES

#17

20190112285

2019-04-18

Aminothiazole derivatives useful as antiviral agents

#18

20190030171

2019-01-31

Phosphonate linkers and their use to facilitate cellular retention of compounds

#19

20180344752

2018-12-06

Thyroid hormone receptor agonist and use thereof

#20

20180303856

2018-10-25

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

#21

20180057450

2018-03-01

Nitrileoxide compound

#22

20170320897

2017-11-09

Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases

#23

20170267704

2017-09-21

Salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof

#24

20170233342

2017-08-17

Derivatives of indole for the treatment of cancer, viral infections and lung diseases

#25

20170232014

2017-08-17

Oligomer-foscarnet conjugates

#26

20170216326

2017-08-03

Use of agonists of formyl peptide receptor 2 for treating dermatological diseases

#27

20170166900

2017-06-15

PEPTIDE NUCLEIC ACID MONOMERS AND OLIGOMERS

#28

20170151375

2017-06-01

Biocompatible, biomimetic ampholyte materials

#29

20160263132

2016-09-15

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

#30

20160200664

2016-07-14

Process for preparing cinacalcet and pharmaceutically acceptable salts thereof

#31

20160060280

2016-03-03

Remote Assembly of Targeted Nanoparticles Using H-Phosphonate -ENE/-YNE Hydrophosphonylation Reactions

#32

20150368280

2015-12-24

HIGH REFRACTIVE INDEX ACRYLIC COMPOUND AND METHOD FOR PREPARING THE SAME

#33

20150336916

2015-11-26

Epoxyeicosatrienoic acid analogs and methods of making and using the same

#34

20150307450

2015-10-29

Derivatives of indole for the treatment of cancer, viral infections and lung diseases

#35

20150246869

2015-09-03

Process for preparing cinacalcet and pharmaceutically acceptable salts thereof

#36

20150225546

2015-08-13

Phosphorous-containing aluminum carboxylate salt flame retardants

#37

20150225430

2015-08-13

Inhibitors of DXP synthase and methods of use thereof

#38

20150197651

2015-07-16

INK COMPOSITION, INKJET RECORDING METHOD, PRINTED MATERIAL, BISACYLPHOSPHINE OXIDE COMPOUND, AND MONOACYLPHOSPHINE OXIDE COMPOUND

#39

20150175637

2015-06-25

Oligomer-foscarnet conjugates

#40

20150158894

2015-06-11

Salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof

#41

20150137666

2015-05-21

Reactive ionic liquid, and ion-immobilized metal oxide particle, ion-immobilized elastomer, and transducer using same

#42

20150031805

2015-01-29

Phosphorus containing flame retardants

#43

20140371446

2014-12-18

Phosphine ligands for catalytic reactions

#44

20140303394

2014-10-09

Synthesis of H-phosphonate intermediates and their use in preparing the herbicide glyphosate

#45

20140288319

2014-09-25

Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts

#46

20140256685

2014-09-11

USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLOGICAL DISEASES

#47

20140256684

2014-09-11

Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases

#48

20140113884

2014-04-24

Epoxyeicosatrienoic acid analogs and methods of making and using the same

#49

20130274479

2013-10-17

Aminohydroxylation of alkenes

#50

20130066098

2013-03-14

Remote assembly of targeted nanoparticles using H-phosphate ENE/-YNE hydrophosphonylation reactions

#51

20130053470

2013-02-28

Biocompatible, biomimetic ampholyte materials

#52

20120270842

2012-10-25

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

#53

20120022252

2012-01-26

Phosphine ligands for catalytic reactions

#54

20110105438

2011-05-05

Oligomer-foscarnet conjugates

#55

20070155975

2007-07-05

Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts

#56

16424338

2024-07-16

Interconnect structure surface modifications by passivating agents